We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Hecla Mining
HL
$14.4B
| $18.6K | ﹤0.01% |
3,097
-171,143
| -98% | -$944K |
|
1727
Photronics
PLAB
$1.78B
| $18.5K | ﹤0.01% |
985
+179
| +22% | +$3.35K |
|
1728
Rush Enterprises Class A
RUSHA
$8.3B
| $18.4K | ﹤0.01% |
+357
| New | +$18.1K |
|
1729
First Merchants
FRME
$2.62B
| $17.7K | ﹤0.01% |
462
+54
| +13% | +$2K |
|
1730
Commercial Vehicle Group
CVGI
$129M
| $17.5K | ﹤0.01% |
10,554
+5,050
| +92% | +$6.14K |
|
1731
Douglas Elliman
DOUG
$169M
| $17.2K | ﹤0.01% |
7,427
+5,901
| +387% | +$12.6K |
|
1732
Diodes
DIOD
$4.18B
| $17.2K | ﹤0.01% |
325
-100
| -24% | -$4.4K |
|
1733
Old Dominion Freight Line
ODFL
$41.5B
| $17K | ﹤0.01% |
105
-18,445
| -99% | -$2.94M |
|
1734
WisdomTree
WT
$3.79B
| $16.9K | ﹤0.01% |
1,464
-581
| -28% | -$5.44K |
|
1735
Standard BioTools
LAB
$256M
| $16.8K | ﹤0.01% |
14,022
+14,020
| +701,000% | +$15.5K |
|
|
TGNA
1736
DELISTED
TEGNA Inc
TGNA
| $16.7K | ﹤0.01% |
999
-283
| -22% | -$4.71K |
|
1737
News Corp Class B
NWS
$19B
| $16.6K | ﹤0.01% |
485
-6
| -1% | -$190 |
|
1738
Group 1 Automotive
GPI
$3.12B
| $16.6K | ﹤0.01% |
38
-13
| -25% | -$5.46K |
|
|
ETNB
1739
DELISTED
89bio
ETNB
| $16.5K | ﹤0.01% |
1,682
-931
| -36% | -$7.71K |
|
|
ELME
1740
Elme Communities
ELME
$148M
| $16.2K | ﹤0.01% |
+1,021
| New | +$16.2K |
|
1741
KRONOS Worldwide
KRO
$1.01B
| $16.2K | ﹤0.01% |
2,609
| – | – |
|
1742
KE Holdings
BEKE
$19.6B
| $16.2K | ﹤0.01% |
911
-2,902,928
| -100% | -$55.8M |
|
1743
Vir Biotechnology
VIR
$1.91B
| $16.1K | ﹤0.01% |
3,186
-15
| -0.5% | -$80 |
|
|
VTYX
1744
DELISTED
Ventyx Biosciences
VTYX
| $16K | ﹤0.01% |
7,470
-2,025
| -21% | -$3.27K |
|
1745
First Community Corp
FCCO
$314M
| $15.8K | ﹤0.01% |
650
+454
| +232% | +$10.5K |
|
1746
CorVel
CRVL
$3.51B
| $15.8K | ﹤0.01% |
154
-93
| -38% | -$10.3K |
|
|
MOFG
1747
DELISTED
MidWestOne Financial Group
MOFG
| $15.6K | ﹤0.01% |
+542
| New | +$15.3K |
|
1748
Finward Bancorp
FNWD
$186M
| $15.5K | ﹤0.01% |
562
+158
| +39% | +$4.67K |
|
1749
Iovance Biotherapeutics
IOVA
$3.74B
| $15.5K | ﹤0.01% |
+9,016
| New | +$22.4K |
|
1750
Collegium Pharmaceutical
COLL
$820M
| $15.4K | ﹤0.01% |
522
-79
| -13% | -$2.25K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.